Mobley Research Laboratory: Department of Microbiology & Immunology: University of Michigan Medical School
 

Proteus mirabillis

References

1. Census-Bureau, U.S., International database, Table 094. Midyear population, by age and sex. 2004: http://www.census.gov/population/www/projections/natdet-D1A.html.

2. Jacobzone, S. and Oxley, Ageing and Health Care Costs. 2002, International Politics and Society: http://fesportal.fes.de/pls/portal30/docs/folder/ipg/ipg1_2002/artjacobzone.htm.

3. Levit, K., C. Smith, C. Cowan, H. Lazenby, A. Sensenig, and A. Catlin, Trends in U.S. health care spending, 2001. Health Aff (Millwood), 2003. 22(1): p. 154-64.

4. Ness, J., A. Ahmed, and W.S. Aronow, Demographics and payment characteristics of nursing home residents in the United States: a 23-year trend. J Gerontol A Biol Sci Med Sci, 2004. 59(11): p. 1213-7.

5. Warren, J.W., J.H. Tenney, J.M. Hoopes, H.L. Muncie, and W.C. Anthony, A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis, 1982. 146(6): p. 719-23.

6. Warren, J.W., D. Damron, J.H. Tenney, J.M. Hoopes, B. Deforge, and H.L. Muncie, Jr., Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J Infect Dis, 1987. 155(6): p. 1151-8.

7. Mobley, H.L. and J.W. Warren, Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol, 1987. 25(11): p. 2216-7.

8. Belas, R., Proteus mirabilis Swarmer Cell Differentiation and Urinary Tract Infection., in Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, J.W. Warren, Editor. 1996, ASM Press: Washington, D.C. p. 271-298.

9. Mobley, H.L., Virulence of Proteus mirabilis, in Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, J.W. Warren, Editor. 1996, ASM Press: Washington, D.C. p. 245-269.

10. Johnson, D.E., R.G. Russell, C.V. Lockatell, J.C. Zulty, J.W. Warren, and H.L. Mobley, Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect Immun, 1993. 61(7): p. 2748-54.

11. Mobley, H.L., G.R. Chippendale, K.G. Swihart, and R.A. Welch, Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells. Infect Immun, 1991. 59(6): p. 2036-42.

12. Rubin, R.H., N.E. Tolkoff-Rubin, and R.S. Cotran, Urinary tract infection, pyelonephritis, and reflux nephropathy., in The Kidney, F.C. Rector, Editor. 1986, W.B. Saunders Col.: Philadelphia. p. 1085-1141.

13. Cox, C.E., A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. Am J Med, 1992. 92(4A): p. 82S-86S.

14. Ehrlich, O. and A.S. Brem, A prospective comparison of urinary tract infections in patients treated with either clean intermittent catheterization or urinary diversion. Pediatrics, 1982. 70(5): p. 665-9.

15. Emori, T.G. and R.P. Gaynes, An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev, 1993. 6(4): p. 428-42.

16. Nicolle, L.E., G.K. Harding, J. Kennedy, M. McIntyre, F. Aoki, and D. Murray, Urine specimen collection with external devices for diagnosis of bacteriuria in elderly incontinent men. J Clin Microbiol, 1988. 26(6): p. 1115-9.

17. Pearman, J.W., M. Bailey, and L.P. Riley, Bladder instillations of trisdine compared with catheter introducer for reduction of bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol, 1991. 67(5): p. 483-90.

18. Schultz, H.J., L.A. McCaffrey, T.F. Keys, and F.T. Nobrega, Acute cystitis: a prospective study of laboratory tests and duration of therapy. Mayo Clin Proc, 1984. 59(6): p. 391-7.

19. Stamm, W.E., M. McKevitt, P.L. Roberts, and N.J. White, Natural history of recurrent urinary tract infections in women. Rev Infect Dis, 1991. 13(1): p. 77-84.

20. Fairley, K.F., N.E. Carson, R.C. Gutch, P. Leighton, A.D. Grounds, E.C. Laird, P.H. McCallum, R.L. Sleeman, and C.M. O'Keefe, Site of infection in acute urinary-tract infection in general practice. Lancet, 1971. 2(7725): p. 615-8.

21. Eriksson, S., J. Zbornik, H. Dahnsjo, P. Erlanson, O. Kahlmeter, H. Fritz, and C.A. Bauer, The combination of pivampicillin and pivmecillinam versus pivampicillin alone in the treatment of acute pyelonephritis. Scand J Infect Dis, 1986. 18(5): p. 431-8.

22. File, T.M., Jr., J.S. Tan, S.J. Salstrom, and L. Johnson, Timentin versus piperacillin in the therapy of serious urinary tract infections. Am J Med, 1985. 79(5B): p. 91-5.

23. Gentry, L.O., B.A. Wood, M.D. Martin, and J. Smythe, Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis. Scand J Infect Dis Suppl, 1980. suppl 25: p. 96-100.

24. Griffith, D.P., D.M. Musher, and C. Itin, Urease. The primary cause of infection-induced urinary stones. Invest Urol, 1976. 13(5): p. 346-50.

25. Hoeniger, J.F., Cellular Changes Accompanying the Swarming of Proteus Mirabilis. I. Observations of Living Cultures. Can J Microbiol, 1964. 10: p. 1-9.

26. Williams, F.D. and R.H. Schwarzhoff, Nature of the swarming phenomenon in Proteus. Annu Rev Microbiol, 1978. 32: p. 101-22.

27. Hoeniger, J.F., Cellular changes accompanying the swarming of Proteus mirabilis. II. Observations of stained organisms. Can J Microbiol, 1966. 12(1): p. 113-23.

28. Mobley, H.L. and R.P. Hausinger, Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev, 1989. 53(1): p. 85-108.

29. Adegbola, R.A. and D.C. Old, Fimbrial haemagglutinins in Enterobacter species. J Gen Microbiol, 1983. 129 (Pt 7): p. 2175-80.

30. Bahrani, F.K., D.E. Johnson, D. Robbins, and H.L. Mobley, Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect Immun, 1991. 59(10): p. 3574-80.

31. Bahrani, F.K., S. Cook, R.A. Hull, G. Massad, and H.L. Mobley, Proteus mirabilis fimbriae: N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequences of the genes from two strains. Infect Immun, 1993. 61(3): p. 884-91.

32. Massad, G., F.K. Bahrani, and H.L. Mobley, Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria. Infect Immun, 1994. 62(5): p. 1989-94.

33. Massad, G. and H.L. Mobley, Genetic organization and complete sequence of the Proteus mirabilis pmf fimbrial operon. Gene, 1994. 150(1): p. 101-4.

34. Old, D.C. and R.A. Adegbola, Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. J Med Microbiol, 1982. 15(4): p. 551-64.

35. Old, D.C. and R.A. Adegbola, Antigenic relationships among type-3 fimbriae of Enterobacteriaceae revealed by immunoelectronmicroscopy. J Med Microbiol, 1985. 20(1): p. 113-21.

36. Bahrani, F.K., G. Massad, C.V. Lockatell, D.E. Johnson, R.G. Russell, J.W. Warren, and H.L. Mobley, Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun, 1994. 62(8): p. 3363-71.

37. Li, X. and H.L. Mobley, MrpB functions as the terminator for assembly of Proteus mirabilis mannose-resistant Proteus-like fimbriae. Infect Immun, 1998. 66(4): p. 1759-63.

38. Li, X., D.E. Johnson, and H.L. Mobley, Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis. Infect Immun, 1999. 67(6): p. 2822-33.

39. Li, X., C.V. Lockatell, D.E. Johnson, M.C. Lane, J.W. Warren, and H.L. Mobley, Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect Immun, 2004. 72(1): p. 66-75.

40. Massad, G., C.V. Lockatell, D.E. Johnson, and H.L. Mobley, Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Infect Immun, 1994. 62(2): p. 536-42.

41. Allison, C., N. Coleman, P.L. Jones, and C. Hughes, Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Infect Immun, 1992. 60(11): p. 4740-6.

42. Mobley, H.L., R. Belas, V. Lockatell, G. Chippendale, A.L. Trifillis, D.E. Johnson, and J.W. Warren, Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Infect Immun, 1996. 64(12): p. 5332-40.

43. Jansen, A.M., C.V. Lockatell, D.E. Johnson, and H.L. Mobley, Visualization of Proteus mirabilis morphotypes in the urinary tract: the elongated swarmer cell is rarely observed in ascending urinary tract infection. Infect Immun, 2003. 71(6): p. 3607-13.

44. Weinberg, E.D., Iron and infection. Microbiol Rev, 1978. 42(1): p. 45-66.

45. Crosa, J.H., Genetics and molecular biology of siderophore-mediated iron transport in bacteria. Microbiol Rev, 1989. 53(4): p. 517-30.

46. Burall, L.S., J.M. Harro, X. Li, C.V. Lockatell, S.D. Himpsl, J.R. Hebel, D.E. Johnson, and H.L. Mobley, Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun, 2004. 72(5): p. 2922-38.

47. Loomes, L.M., B.W. Senior, and M.A. Kerr, A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes. Infect Immun, 1990. 58(6): p. 1979-85.

48. Loomes, L.M., B.W. Senior, and M.A. Kerr, Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients. Infect Immun, 1992. 60(6): p. 2267-73.

49. Senior, B.W., M. Albrechtsen, and M.A. Kerr, Proteus mirabilis strains of diverse type have IgA protease activity. J Med Microbiol, 1987. 24(2): p. 175-80.

50. Walker, K.E., S. Moghaddame-Jafari, C.V. Lockatell, D. Johnson, and R. Belas, ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells. Mol Microbiol, 1999. 32(4): p. 825-36.

51. Wassif, C., D. Cheek, and R. Belas, Molecular analysis of a metalloprotease from Proteus mirabilis. J Bacteriol, 1995. 177(20): p. 5790-8.

52. Murphy, C.A. and R. Belas, Genomic rearrangements in the flagellin genes of Proteus mirabilis. Mol Microbiol, 1999. 31(2): p. 679-90.

53. Li, X., D.A. Rasko, C.V. Lockatell, D.E. Johnson, and H.L. Mobley, Repression of bacterial motility by a novel fimbrial gene product. Embo J, 2001. 20(17): p. 4854-62.

54. Zhao, H., X. Li, D.E. Johnson, I. Blomfield, and H.L. Mobley, In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol Microbiol, 1997. 23(5): p. 1009-19.

55. Chippendale, G.R., J.W. Warren, A.L. Trifillis, and H.L. Mobley, Internalization of Proteus mirabilis by human renal epithelial cells. Infect Immun, 1994. 62(8): p. 3115-21.

56. Jones, B.D., C.V. Lockatell, D.E. Johnson, J.W. Warren, and H.L. Mobley, Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun, 1990. 58(4): p. 1120-3.

57. Saint, S. and C.E. Chenoweth, Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am, 2003. 17(2): p. 411-32.

58. Sabbuba, N., G. Hughes, and D.J. Stickler, The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int, 2002. 89(1): p. 55-60.

59. Morris, N.S. and D.J. Stickler, Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine. J Hosp Infect, 1998. 39(3): p. 227-34.

60. Stickler, D.J., Bacterial biofilms and the encrustation of urethral catheters. Biofouling, 1996. 94: p. 293-305.

61. Poore, C.A., C. Coker, J.D. Dattelbaum, and H.L. Mobley, Identification of the domains of UreR, an AraC-like transcriptional regulator of the urease gene cluster in Proteus mirabilis. J Bacteriol, 2001. 183(15): p. 4526-35.

62. Gendlina, I., D.M. Gutman, V. Thomas, and C.M. Collins, Urea-dependent signal transduction by the virulence regulator UreR. J Biol Chem, 2002. 277(40): p. 37349-58.

63. Jones, B.D. and H.L. Mobley, Proteus mirabilis urease: nucleotide sequence determination and comparison with jack bean urease. J Bacteriol, 1989. 171(12): p. 6414-22.

64. Jones, B.D. and H.L. Mobley, Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes. J Bacteriol, 1988. 170(8): p. 3342-9.

65. Jansen, A.M., C.V. Lockatell, D.E. Johnson, and H.L.T. Mobley, Expression of Mannose-Resistant/Proteus-Like (MR/P) Fimbriae Mediates Autoaggregation and Localization of Proteus mirabilis to the Bladder Surface During Ascending Urinary Tract Infection. iInfect & Immun, 2003.

66. Li, X., C.V. Lockatell, D.E. Johnson, and H.L. Mobley, Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis. Mol Microbiol, 2002. 45(3): p. 865-74.

67. Jansen, A.M., C.V. Lockatell, D.E. Johnson, and H.L.T. Mobley, Visualization of Proteus mirabilis Morphotypes in the Urinary Tract: the Elongated Swarmer Cell Is Rarely Observed in Ascending Urinary Tract Infection. Infect. Immun., 2003. 71(6): p. 3607-3613.

68. Jansen, A.M., V. Lockatell, D.E. Johnson, and H.L. Mobley, Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect Immun, 2004. 72(12): p. 7294-305.

69. Belas, R. and D. Flaherty, Sequence and genetic analysis of multiple flagellin-encoding genes from Proteus mirabilis. GENE, 1994. 128: p. 33-41.

70. Chippendale, G.R., J.W. Warren, A.L. Trifiles, and H.L. Mobley, Internalization of Proteus mirabilis by Human Renal Epithelial Cells. Infection and Immunity, 1994.

71. Fowler, J.E., Jr., Bacteriology of branched renal calculi and accompanying urinary tract infection. J Urol, 1984. 131(2): p. 213-5.

72. Warren, J.W., H.L. Muncie, Jr., J.R. Hebel, and M. Hall-Craggs, Long-term urethral catheterization increases risk of chronic pyelonephritis and renal inflammation. J Am Geriatr Soc, 1994. 42(12): p. 1286-90.

73. Mobley, H.L. and G.R. Chippendale, Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. J Infect Dis, 1990. 161(3): p. 525-30.

74. Senior, B.W., Proteus morgani is less frequently associated with urinary tract infections than Proteus mirabilis--an explanation. J Med Microbiol, 1983. 16(3): p. 317-22.

75. Pellegrino, R., U. Galvalisi, P. Scavone, V. Sosa, and P. Zunino, Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. FEMS Immunol Med Microbiol, 2003. 36(1-2): p. 103-10.

76. Moayeri, N., C.M. Collins, and P. O'Hanley, Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model. Infect Immun, 1991. 59(10): p. 3778-86.

77. Pazin, G.J. and A.I. Braude, Immobilizing antibodies in pyelonephritis. J Immunol, 1969. 102(6): p. 1454-65.